Our Company

BioGenex designs, develops and commercializes molecular pathology systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology. Proprietary fully-automated molecular pathology workstations from BioGenex are the most advanced systems available globally. BioGenex prides itself on delivering cutting edge technology, years ahead of the competition, providing the finest systems for immunohistochemistry (IHC), in situ hybridization (ISH), Fluorescence ISH (FISH) and in situ PCR. BioGenex systems and product performance are guaranteed: antibodies, probes, antigen retrieval, detection systems, and histology stains. We provide quality systems and are committed to best in class customer care.

Facts and Figures

Mission To become a global molecular medicine company providing
affordable solutions for life science research and personalized
Founders Krishan L. Kalra, Ph.D., Satya Kalra
CEO Krishan L. Kalra, Ph.D.
Incorporation San Ramon, California, 1981
Industry Tissue and cell-based Tumor diagnostics
Locations Headquarters: Fremont, California, USA
Regional Center of Excellence: Hyderabad, India
Manufacturing Sites: Fremont, California, USA and Hyderabad, India
Agency Office: Shanghai, China
Wholly Owned Subsidiary in Europe: Milan, Italy
Customer Service Centers: Fremont, Hyderabad, Shanghai and Milan
Regulatory Certifications ISO 13485 (2016), ISO 9001 (2015), cGMP, IVD – CE certified
Number of Employees 250+ globally
Product Areas Multiple fully automated molecular pathology workstations
Immunohistochemistry (IHC)
In-situ hybridization (ISH)
Fluorescence in-situ hybridization (FISH)
In-situ PCR
Multiplex stains
MicroRNA and HPV probe system
Flagship Products Xmatrx® systems, i6000™ systems, i500 Plus™, NanoVIP®, Xmatrx® MINI, EZ-Retriever®, IHC primary antibodies, microRNA probes,  IHC/ISH
detection kits
Global Reach 70+ distributors across 47 countries
Customers Pathologists, histotechnologists, reference labs, clinical lab
professionals, pharmaceutical/biotechnology and academic
Patents 25 US and foreign patents granted
28 US and foreign patents pending

Mission Statement

Mission Statement